Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor-Reference-Cited by-同舟云学术

Characterization and drug sensitivity of a novel human ovarian clear cell carcinoma cell line genomically and phenotypically similar to the original tumor

Published:2018-08-14 Issue:9 Volume:7 Page:4744-4754
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Franklin Miriam¹²,Gentles Lucy¹,Matheson Elizabeth¹,Bown Nick³,Cross Paul⁴,Ralte Angela⁴,Gilkes‐Immeson Connor¹,Bradbury Alice¹,Zanjirband Maryam¹⁵,Lunec John¹,Drew Yvette¹⁶,O'Donnell Rachel¹⁷,Curtin Nicola J.¹^ORCID

Affiliation:

1. Northern Institute for Cancer ResearchMedical SchoolNewcastle University Newcastle upon Tyne UK

2. Division of Cancer SciencesSchool of Medical SciencesFaculty of Biology, Medicine and HealthUniversity of Manchester Manchester UK

3. Northern Genetics ServiceInstitute of Genetic Medicine Newcastle upon Tyne UK

4. Pathology DepartmentQueen Elizabeth Hospital Gateshead UK

5. Department of BiologyFaculty of ScienceUniversity of Isfahan Isfahan Iran

6. Northern Centre for Cancer CareFreeman Hospital Newcastle upon Tyne UK

7. Northern Gynaecological Oncology CentreQueen Elizabeth Hospital Gateshead UK

Funder

JGW Patterson Foundation

Medical Research Council

Wellcome Trust

Newcastle University

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.1724

Reference38 articles.

1. World Cancer Research Fund International webpage.http://www.wcrf.org/int/cancer-facts-figures/data-specific-cancers/ovarian-cancer-statistics. Accessed July 30 2018.

2. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial

3. The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory

4. The Use of Ovarian Cancer Cells from Patients Undergoing Surgery to Generate Primary Cultures Capable of Undergoing Functional Analysis

5. PARP inhibitors in ovarian cancer

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Establishment of a human ovarian clear cell carcinoma cell line mutant in PIK3CB but not PIK3CA;Human Cell;2024-04-04

2. Comparative analysis of response to treatments and molecular features of tumor-derived organoids versus cell lines and PDX derived from the same ovarian clear cell carcinoma;Journal of Experimental & Clinical Cancer Research;2023-10-07

3. miR-16-5p enhances sensitivity to RG7388 through targeting PPM1D expression (WIP1) in Childhood Acute Lymphoblastic Leukemia;Cancer Drug Resistance;2023

4. The Role of ATR Inhibitors in Ovarian Cancer: Investigating Predictive Biomarkers of Response;Cells;2022-08-01

5. Characterization of rare histological subtypes of ovarian cancer based on molecular profiling;Cancer Medicine;2022-06-08